These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28914734)

  • 1. Revisiting the concept of amyotrophic lateral sclerosis as a multisystems disorder of limited phenotypic expression.
    Strong MJ
    Curr Opin Neurol; 2017 Dec; 30(6):599-607. PubMed ID: 28914734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in clinical neurosciences: the evidence for ALS as a multisystems disorder of limited phenotypic expression.
    Strong MJ
    Can J Neurol Sci; 2001 Nov; 28(4):283-98. PubMed ID: 11766772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defects in optineurin- and myosin VI-mediated cellular trafficking in amyotrophic lateral sclerosis.
    Sundaramoorthy V; Walker AK; Tan V; Fifita JA; Mccann EP; Williams KL; Blair IP; Guillemin GJ; Farg MA; Atkin JD
    Hum Mol Genet; 2015 Jul; 24(13):3830-46. PubMed ID: 25859013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis.
    Laferriere F; Polymenidou M
    Swiss Med Wkly; 2015; 145():w14054. PubMed ID: 25635517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and Clinical Management of Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders.
    Goutman SA
    Continuum (Minneap Minn); 2017 Oct; 23(5, Peripheral Nerve and Motor Neuron Disorders):1332-1359. PubMed ID: 28968365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis.
    Blair IP; Williams KL; Warraich ST; Durnall JC; Thoeng AD; Manavis J; Blumbergs PC; Vucic S; Kiernan MC; Nicholson GA
    J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):639-45. PubMed ID: 19965854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and therapeutic perspectives in amyotrophic lateral sclerosis.
    Mathis S; Couratier P; Julian A; Vallat JM; Corcia P; Le Masson G
    Expert Rev Neurother; 2017 Mar; 17(3):263-276. PubMed ID: 27644548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between amyotrophic lateral sclerosis and frontotemporal dementia.
    Ringholz GM; Greene SR
    Curr Neurol Neurosci Rep; 2006 Sep; 6(5):387-92. PubMed ID: 16928348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy metabolism in amyotrophic lateral sclerosis.
    Dupuis L; Pradat PF; Ludolph AC; Loeffler JP
    Lancet Neurol; 2011 Jan; 10(1):75-82. PubMed ID: 21035400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TDP-43 in differential diagnosis of motor neuron disorders.
    Dickson DW; Josephs KA; Amador-Ortiz C
    Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of recent breakthroughs in amyotrophic lateral sclerosis.
    Van Damme P; Robberecht W
    Curr Opin Neurol; 2013 Oct; 26(5):466-72. PubMed ID: 23945281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology.
    Ince PG; Lowe J; Shaw PJ
    Neuropathol Appl Neurobiol; 1998 Apr; 24(2):104-17. PubMed ID: 9634206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporadic amyotrophic lateral sclerosis: Widespread multisystem degeneration with TDP-43 pathology in a patient after long-term survival on a respirator.
    Nishihira Y; Tan CF; Toyoshima Y; Yonemochi Y; Kondo H; Nakajima T; Takahashi H
    Neuropathology; 2009 Dec; 29(6):689-96. PubMed ID: 19170893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
    Baloh RH
    Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyotrophic lateral sclerosis: contemporary concepts in etiopathogenesis and pharmacotherapy.
    Strong MJ
    Expert Opin Investig Drugs; 2004 Dec; 13(12):1593-614. PubMed ID: 15566317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the gamma loop in ALS.
    Limanaqi F; Gambardella S; Lazzeri G; Ferrucci M; Ruggieri S; Fornai F
    Arch Ital Biol; 2017 Dec; 155(4):118-130. PubMed ID: 29405034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutrient Effects on Motor Neurons and the Risk of Amyotrophic Lateral Sclerosis.
    Goncharova PS; Davydova TK; Popova TE; Novitsky MA; Petrova MM; Gavrilyuk OA; Al-Zamil M; Zhukova NG; Nasyrova RF; Shnayder NA
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration.
    Iguchi Y; Katsuno M; Niwa J; Takagi S; Ishigaki S; Ikenaka K; Kawai K; Watanabe H; Yamanaka K; Takahashi R; Misawa H; Sasaki S; Tanaka F; Sobue G
    Brain; 2013 May; 136(Pt 5):1371-82. PubMed ID: 23449777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
    JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Update on fundamental and clinical research in amyotrophic lateral sclerosis].
    Pradat PF; Camdessanché JP; Carluer L; Cintas P; Corcia P; Danel-Brunaud V; Echaniz-Laguna A; Gonzalez J; Nicolas G; Vandenberghe N; Verschueren A;
    Rev Neurol (Paris); 2009; 165(6-7):532-41. PubMed ID: 19419744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.